Bank of New York Mellon Corp lowered its stake in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 3.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 416,091 shares of the business services provider's stock after selling 13,196 shares during the quarter. Bank of New York Mellon Corp owned about 0.82% of Exponent worth $33,728,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors have also recently modified their holdings of EXPO. Norges Bank acquired a new stake in shares of Exponent in the 4th quarter valued at about $52,381,000. Resona Asset Management Co. Ltd. bought a new position in Exponent in the 4th quarter worth approximately $38,538,000. BLI Banque de Luxembourg Investments acquired a new stake in shares of Exponent during the 4th quarter valued at $12,564,000. Barclays PLC increased its stake in shares of Exponent by 88.5% in the fourth quarter. Barclays PLC now owns 181,921 shares of the business services provider's stock worth $16,209,000 after acquiring an additional 85,395 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership increased its position in Exponent by 1,061.1% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 85,790 shares of the business services provider's stock worth $7,644,000 after buying an additional 78,401 shares during the last quarter. 92.37% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling at Exponent
In other news, VP Joseph Rakow sold 1,573 shares of the business's stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $77.72, for a total transaction of $122,253.56. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP John Pye sold 2,000 shares of the stock in a transaction dated Friday, May 23rd. The stock was sold at an average price of $76.32, for a total transaction of $152,640.00. Following the transaction, the vice president owned 29,204 shares in the company, valued at approximately $2,228,849.28. The trade was a 6.41% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 6,267 shares of company stock worth $489,120. 1.60% of the stock is owned by corporate insiders.
Exponent Stock Performance
EXPO traded down $1.55 during trading on Friday, reaching $72.51. 258,694 shares of the company's stock were exchanged, compared to its average volume of 263,677. Exponent, Inc. has a fifty-two week low of $71.72 and a fifty-two week high of $115.75. The firm has a market capitalization of $3.68 billion, a PE ratio of 35.37 and a beta of 0.90. The company's fifty day moving average price is $76.26 and its 200-day moving average price is $81.56.
Exponent (NASDAQ:EXPO - Get Free Report) last announced its earnings results on Thursday, May 1st. The business services provider reported $0.52 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.48 by $0.04. The firm had revenue of $137.44 million for the quarter, compared to analyst estimates of $134.63 million. Exponent had a net margin of 18.87% and a return on equity of 25.33%. The business's revenue was up .2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.59 EPS. Research analysts forecast that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.
Exponent Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, June 20th. Investors of record on Friday, June 6th were paid a $0.30 dividend. The ex-dividend date of this dividend was Friday, June 6th. This represents a $1.20 annualized dividend and a dividend yield of 1.65%. Exponent's payout ratio is 58.54%.
Exponent Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Articles

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.